Do small airway abnormalities characterize asthma phenotypes? In search of proof

Clinical and Experimental Allergy

Volumn 42, Issue 8, 2012, Pages 1150-1160

  Contoli, M ^a   Kraft, M ^b   Hamid, Q ^c   Bousquet, J ^d   Rabe, K F ^e   Fabbri, L M ^f   Papi, A ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIV MONTPELLIER   (France)

^e KRANKENHAUS GROSSHANSDORF   (Germany)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Asthma; Inflammation; Phenotypes; Small airways

Indexed keywords

BECLOMETASONE; FLUTICASONE; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; HISTONE DEACETYLASE 2; INTERLEUKIN 13; INTERLEUKIN 1BETA; NITRIC OXIDE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY OBSTRUCTION; AIRWAY REMODELING; AIRWAY RESISTANCE; ALLOPATHY; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; AUTOPSY; CIGARETTE SMOKING; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; EVIDENCE BASED PRACTICE; FORCED VITAL CAPACITY; HUMAN; INFLAMMATORY CELL; LUNG COMPLIANCE; LUNG LAVAGE; PEAK EXPIRATORY FLOW; PHENOTYPE; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY TRACT INFLAMMATION; REVIEW; SMALL AIRWAY DISEASE; TOTAL LUNG CAPACITY; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION;

AGE FACTORS; ASTHMA; BRONCHI; HUMANS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84864003920     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.03963.x     Document Type: Review

References (102)

1. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA), 2011. Available from: (last accessed 1 December 2011).
2. Burgel PR. The role of small airways in obstructive airway diseases. Eur Respir Rev 2011; 20:23-33.
3. Contoli M, Bousquet J, Fabbri LM et al. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy 2010; 125:830-7.
4. Scichilone N, Battaglia S, Olivieri D, Bellia V. The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1? Allergy 2009; 64:1563-9.
5. Usmani OS, Barnes PJ. Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease. Ann Med 2012; 44:146-56.
6. van den Berge M, ten Hacken NH, Cohen J, Douma WR, Postma DS. Small airway disease in asthma and COPD: clinical implications. Chest 2011; 139:412-23.
7. Carroll N, Carello S, Cooke C, James A. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J 1996; 9:709-15.
8. Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur Respir J 1997; 10:292-300.
9. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993; 147:405-10.
10. Christodoulopoulos P, Leung DY, Elliott MW et al. Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma. J Allergy Clin Immunol 2000; 106:479-84.
11. de Magalhaes Simoes S, dos Santos MA, da Silva Oliveira M et al. Inflammatory cell mapping of the respiratory tract in fatal asthma. Clin Exp Allergy 2005; 35:602-11.
12. Faul JL, Tormey VJ, Leonard C et al. Lung immunopathology in cases of sudden asthma death. Eur Respir J 1997; 10:301-7.
13. Haley KJ, Sunday ME, Wiggs BR et al. Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med 1998; 158:565-72.
14. James AL, Pare PD, Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989; 139:242-6.
15. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148:1220-5.
16. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143:138-43.
17. Balzar S, Chu HW, Strand M, Wenzel S. Relationship of small airway chymase-positive mast cells and lung function in severe asthma. Am J Respir Crit Care Med 2005; 171:431-9.
18. Hamid Q, Song Y, Kotsimbos TC et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100:44-51.
19. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154:1505-10.
20. Kraft M, Martin RJ, Wilson S, Djukanovic R, Holgate ST. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 1999; 159:228-34.
21. Minshall EM, Hogg JC, Hamid QA. Cytokine mRNA expression in asthma is not restricted to the large airways. J Allergy Clin Immunol 1998; 101:386-90.
22. Taha RA, Minshall EM, Miotto D et al. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J Allergy Clin Immunol 1999; 103:476-83.
23. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997; 156:737-43.
24. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010; 182:598-604.
25. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368:804-13.
26. Bousquet J, Mantzouranis E, Cruz AA et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126:926-38.
27. Bergeron C, Hauber HP, Gotfried M et al. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. J Allergy Clin Immunol 2006; 116:983-89.
28. Dolhnikoff M, da Silva LF, de Araujo BB et al. The outer wall of small airways is a major site of remodeling in fatal asthma. J Allergy Clin Immunol 2009; 123:1090-7.
29. Tsoukias NM, Shin HW, Wilson AF, George SC. A single-breath technique with variable flow rate to characterize nitric oxide exchange dynamics in the lungs. J Appl Physiol 2001; 91:477-87.
30. Lehtimaki L, Kankaanranta H, Saarelainen S et al. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 2001; 163:1557-61.
31. Mahut B, Delclaux C, Tillie-Leblond I et al. Both inflammation and remodeling influence nitric oxide output in children with refractory asthma. J Allergy Clin Immunol 2004; 113:252-6.
32. Berry M, Hargadon B, Morgan A et al. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J 2005; 25:986-91.
33. Jiang J, Malavia N, Suresh V, George SC. Nitric oxide gas phase release in human small airway epithelial cells. Respir Res 2009; 10:3.
34. Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest 2007; 131:1353-62.
35. van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006; 27:951-6.
36. Mahut B, Trinquart L, Le Bourgeois M et al. Multicentre trial evaluating alveolar NO fraction as a marker of asthma control and severity. Allergy 2010; 65:636-44.
37. Gershman NH, Liu H, Wong HH, Liu JT, Fahy JV. Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. J Allergy Clin Immunol 1999; 104:322-8.
38. Richter K, Holz O, Jorres RA, Mucke M, Magnussen H. Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease. Eur Respir J 1999; 14:697-701.
39. Taha R, Hamid Q, Olivenstein R. Fractional analysis of Th2-type cytokines in sequential samples of induced sputum. Can Respir J 2004; 11:146-50.
40. Wagner EM, Bleecker ER, Permutt S, Liu MC. Direct assessment of small airways reactivity in human subjects. Am J Respir Crit Care Med 1998; 157:447-52.
41. Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992; 72:1016-23.
42. Ueda T, Niimi A, Matsumoto H et al. Role of small airways in asthma: investigation using high-resolution computed tomography. J Allergy Clin Immunol 2006; 118:1019-25.
43. Sorkness RL, Bleecker ER, Busse WW et al. Blood Institute Severe Asthma Research Program. Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol 2008; 104:394-403.
44. Beigelman-Aubry C, Capderou A, Grenier PA et al. Mild intermittent asthma: CT assessment of bronchial cross-sectional area and lung attenuation at controlled lung volume. Radiology 2002; 223:181-7.
45. Laurent F, Latrabe V, Raherison C, Marthan R, Tunon-de-Lara JM. Functional significance of air trapping detected in moderate asthma. Eur Radiol 2000; 10:1404-10.
46. Busacker A, Newell JD Jr, Keefe T et al. A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest 2009; 135:48-56.
47. Bel EH, Sousa A, Fleming L et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011; 66:910-7.
48. Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006; 368:780-93.
49. Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med 2005; 172:149-60.
50. Caramori G, Oates T, Nicholson AG et al. Activation of NF-kappaB transcription factor in asthma death. Histopathology 2009; 54:507-9.
51. den Otter I, Silva LF, Carvalho AL et al. High-affinity immunoglobulin E receptor expression is increased in large and small airways in fatal asthma. Clin Exp Allergy 2010; 40:1473-81.
52. Mauad T, Silva LFF, Santos MA et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am J Respir Crit Care Med 2004; 170:857-62.
53. Balzar S, Wenzel SE, Chu HW. Transbronchial biopsy as a tool to evaluate small airways in asthma. Eur Respir J 2002; 20:254-9.
54. Dolan CM, Fraher KE, Bleecker ER et al. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 2004; 92:32-9.
55. Haldar P, Pavord ID, Shaw DE et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178:218-24.
56. Moore WC, Bleecker ER, Curran-Everett D et al. Blood Institute's Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119:405-13.
57. The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003; 22:470-77.
58. Wenzel SE, Fahy JV, Irvin CG, Peters SP, Spector S, Szefler SJ. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000; 162:2341-51.
59. In 't Veen JC, Beekman AJ, Bel EH, Sterk PJ. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 2000; 161:1902-6.
60. Bourdin A, Paganin F, Prefaut C, Kieseler D, Godard P, Chanez P. Nitrogen washout slope in poorly controlled asthma. Allergy 2006; 61:85-9.
61. Goldman MD. Clinical application of forced oscillation. Pulm Pharmacol Ther 2001; 14:341-50.
62. Shi Y, Aledia AS, Tatavoosian AV, Vijayalakshmi S, Galant SP, George SC. Relating small airways to asthma control by using impulse oscillometry in children. J Allergy Clin Immunol 2012; 129:671-8.
63. Gibson PG, Mcdonald VM, Marks GB. Asthma in older adults. Lancet 2010; 376:803-13.
64. Bellia V, Scichilone N, Battaglia S. Asthma in the elderly. In: Bellia V, Antonelli Incalzi R, eds. Respiratory diseases in the elderly. Sheffield: Eur Respir Mon, 2009:56-73.
65. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339:1194-200.
66. Bellia V, Cibella F, Cuttitta G et al. Effect of age upon airway obstruction and reversibility in adult patients with asthma. Chest 1998; 114:1336-42.
67. Cassino C, Berger KI, Goldring RM et al. Duration of asthma and physiologic outcomes in elderly nonsmokers. Am J Respir Crit Care Med 2000; 162:1423-8.
68. Kizkin O, Turker G, Hacievliyagil SS, Gunen H. Asthma, age, and early reversibility testing. J Asthma 2003; 40:317-21.
69. Verbeken EK, Cauberghs M, Mertens I, Clement J, Lauweryns JM, Van de Woestijne KP. The senile lung. Comparison with normal and emphysematous lungs. 2. Functional aspects. Chest 1992; 101:800-9.
70. Verbeken EK, Cauberghs M, Mertens I, Clement J, Lauweryns JM, Van deWoestijne KP. The senile lung. Comparison with normal and emphysematous lungs. 1. Structural aspects. Chest 1992; 101:793-9.
71. Barnes PJ. Pathophysiology of asthma. In: Asthma Chung F, Fabbri LM, eds. European respiratory monograph, Sheffield: ERS Journals Ltd, 2003:84-113.
72. Fabbri LM, Romagnoli M, Corbetta L et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167:418-24.
73. Contoli M, Baraldo S, Marku B et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol 2010; 125:830-7.
74. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med 2009; 15:39-45.
75. Pedersen SE, Bateman ED, Bousquet J, Busse WW, Yoxall S, Clark TJ. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. J Allergy Clin Immunol 2007; 120:1036-42.
76. Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J 2008; 31:320-5.
77. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002; 57:226-30.
78. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168:1308-11.
79. Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005; 60:282-7.
80. Lazarus SC, Chinchilli VM, Rollings NJ et al. Network NHLaBIsACR, Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007; 175:783-90.
81. Spears M, Donnelly I, Jolly L et al. Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study. Eur Respir J 2009; 33:1010-7.
82. Boulet LP, Lemiere C, Archambault F, Carrier G, Descary MC, Deschesnes F. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest 2006; 129:661-8.
83. Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest 2001; 120:1917-22.
84. Livingston E, Chaudhuri R, McMahon AD, Fraser I, McSharry CP, Thomson NC. Systemic sensitivity to corticosteroids in smokers with asthma. Eur Respir J 2007; 29:64-71.
85. Broekema M, ten Hacken NH, Volbeda F et al. Airway epithelial changes in smokers but not in ex-smokers with asthma. Am J Respir Crit Care Med 2009; 180:1170-8.
86. Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol 2007; 119:1043-52; quiz 53-4.
87. Livingston E, Darroch CE, Chaudhuri R et al. Glucocorticoid receptor alpha: beta ratio in blood mononuclear cells is reduced in cigarette smokers. J Allergy Clin Immunol 2004; 114:1475-8.
88. Cosio BG, Mann B, Ito K et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med 2004; 170:141-7.
89. Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001; 15:1110-2.
90. Lee JJ, Liu D, Lee JS et al. Long-term impact of smoking on lung epithelial proliferation in current and former smokers. J Natl Cancer Inst 2001; 93:1081-8.
91. Invernizzi G, Ruprecht A, De Marco C, Mazza R, Nicolini G, Boffi R. Inhaled steroid/tobacco smoke particle interactions: a new light on steroid resistance. Respir Res 2009; 10:48.
92. Amin K, Ekberg-Jansson A, Lofdahl CG, Venge P. Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study. Thorax 2003; 58:135-42.
93. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983; 128:833-8.
94. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996; 9:1989-94.
95. Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin DP. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med 1998; 157:928-37.
96. Cosio M, Ghezzo H, Hogg JC et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978; 298:1277-81.
97. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291:755-8.
98. Stanescu D, Sanna A, Veriter C, Robert A. Identification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-up. Chest 1998; 114:416-25.
99. Goldin JG, Tashkin DP, Kleerup EC et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 1999; 104:S258-67.
100. Verbanck S, Schuermans D, Paiva M, Vincken W. The functional benefit of anti-inflammatory aerosols in the lung periphery. J Allergy Clin Immunol 2006; 118:340-6.
101. Cohen J, Douma WR, ten Hacken NHT, Vonk JM, Oudkerk M, Postma DS. Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J 2008; 31:1213-20.
102. Scichilone N, Battaglia S, Sorino C et al. Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. Allergy 2010; 65:897-902.